NDC 0003-0249 Halog
Halcinonide
NDC Product Code 0003-0249
NDC Code: 0003-0249
Proprietary Name: Halog
What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name: HalcinonideWhat is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Code Structure
Proprietary Name: Halog
What is the Proprietary Name?The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name: Halcinonide
What is the Non-Proprietary Name?The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Code Structure
- 0003 - E.r. Squibb & Sons, L.l.c.
- 0003-0249 - Halog
NDC 0003-0249-15
Package Description: 20 mL in 1 BOTTLE, PLASTIC
NDC 0003-0249-20
Package Description: 60 mL in 1 BOTTLE, PLASTIC
NDC Product Information
Halog with NDC 0003-0249 is a a human prescription drug product labeled by E.r. Squibb & Sons, L.l.c.. The generic name of Halog is halcinonide. The product's dosage form is solution and is administered via topical form.
Labeler Name: E.r. Squibb & Sons, L.l.c.Dosage Form: Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Product Type: Human Prescription Drug
What kind of product is this?Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
Halog Active Ingredient(s)
What is the Active Ingredient(s) List?This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Administration Route(s)
What are the Administration Route(s)?The translation of the route code submitted by the firm, indicating route of administration.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Pharmacological Class(es)
What is a Pharmacological Class?These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.
- Corticosteroid - [EPC] (Established Pharmacologic Class)
- Corticosteroid Hormone Receptor Agonists - [MoA] (Mechanism of Action)
Product Labeler Information
What is the Labeler Name?Name of Company corresponding to the labeler code segment of the Product NDC.
Labeler Name: E.r. Squibb & Sons, L.l.c.
Labeler Code: 0003
FDA Application Number: NDA017823What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Marketing Category: NDA - A product marketed under an approved New Drug Application.What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Start Marketing Date: 01-01-2009What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.
Labeler Code: 0003
FDA Application Number: NDA017823
What is the FDA Application Number?This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Marketing Category: NDA - A product marketed under an approved New Drug Application.
What is the Marketing Category?Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Start Marketing Date: 01-01-2009
What is the Start Marketing Date?This is the date that the labeler indicates was the start of its marketing of the drug product.
* Please review the disclaimer below.